Metformin: historical overview

被引:0
作者
Clifford J. Bailey
机构
[1] Aston University,School of Life and Health Sciences
来源
Diabetologia | 2017年 / 60卷
关键词
Biguanide; Dimethylbiguanide; Guanidine; History; Jean Sterne; Metformin; Review; Type 2 diabetes;
D O I
暂无
中图分类号
学科分类号
摘要
Metformin (dimethylbiguanide) has become the preferred first-line oral blood glucose-lowering agent to manage type 2 diabetes. Its history is linked to Galega officinalis (also known as goat’s rue), a traditional herbal medicine in Europe, found to be rich in guanidine, which, in 1918, was shown to lower blood glucose. Guanidine derivatives, including metformin, were synthesised and some (not metformin) were used to treat diabetes in the 1920s and 1930s but were discontinued due to toxicity and the increased availability of insulin. Metformin was rediscovered in the search for antimalarial agents in the 1940s and, during clinical tests, proved useful to treat influenza when it sometimes lowered blood glucose. This property was pursued by the French physician Jean Sterne, who first reported the use of metformin to treat diabetes in 1957. However, metformin received limited attention as it was less potent than other glucose-lowering biguanides (phenformin and buformin), which were generally discontinued in the late 1970s due to high risk of lactic acidosis. Metformin’s future was precarious, its reputation tarnished by association with other biguanides despite evident differences. The ability of metformin to counter insulin resistance and address adult-onset hyperglycaemia without weight gain or increased risk of hypoglycaemia gradually gathered credence in Europe, and after intensive scrutiny metformin was introduced into the USA in 1995. Long-term cardiovascular benefits of metformin were identified by the UK Prospective Diabetes Study (UKPDS) in 1998, providing a new rationale to adopt metformin as initial therapy to manage hyperglycaemia in type 2 diabetes. Sixty years after its introduction in diabetes treatment, metformin has become the most prescribed glucose-lowering medicine worldwide with the potential for further therapeutic applications.
引用
收藏
页码:1566 / 1576
页数:10
相关论文
共 50 条
  • [21] The mechanisms of action of metformin
    Rena, Graham
    Hardie, D. Grahame
    Pearson, Ewan R.
    DIABETOLOGIA, 2017, 60 (09) : 1577 - 1585
  • [22] Systematic reviews: A brief historical overview
    Hong, Quan Nha
    Pluye, Pierre
    EDUCATION FOR INFORMATION, 2018, 34 (04) : 261 - 276
  • [23] A historical overview of the ozone exposure problem
    Madden, MC
    Hogsett, WE
    HUMAN AND ECOLOGICAL RISK ASSESSMENT, 2001, 7 (05): : 1121 - 1131
  • [24] Sport and Environment in Brazil: A Historical Overview
    Dias, Cleber
    INTERNATIONAL JOURNAL OF THE HISTORY OF SPORT, 2014, 31 (10) : 1255 - 1266
  • [25] Historical overview of wound ballistics research
    Maiden, Nick
    FORENSIC SCIENCE MEDICINE AND PATHOLOGY, 2009, 5 (02) : 85 - 89
  • [26] Inherited predisposition to cancer: A historical overview
    Lynch, HT
    Shaw, TG
    Lynch, JF
    AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2004, 129C (01) : 5 - 22
  • [27] Stendhal syndrome: a clinical and historical overview
    Palacios-Sanchez, Leonardo
    Botero-Meneses, Juan Sebastian
    Pachon, Rocio Plazas
    Pineros Hernandez, Laura Bibiana
    Triana-Melo, Juanita del Pilar
    Ramirez-Rodriguez, Santiago
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2018, 76 (02) : 120 - 123
  • [28] Music education in prisons: A historical overview
    Lee, Roc
    INTERNATIONAL JOURNAL OF COMMUNITY MUSIC, 2010, 3 (01) : 7 - 17
  • [29] Historical overview of studies on inflammation in Russia
    Liudmila Buryachkovskaya
    Alexander Sumarokov
    Nikita Lomakin
    Inflammation Research, 2013, 62 : 441 - 450
  • [30] Ethnographic studies of childhood: A historical overview
    LeVine, Robert A.
    AMERICAN ANTHROPOLOGIST, 2007, 109 (02) : 247 - 260